Palonosetron
Spécifications
135729-61-2Numéro CAS
(3aS)-2-[(3S)-1-azabicyclo[2.2.2]octan-3-yl]-3a,4,5,6-tetrahydro-3H-benzo[de]isoquinolin-1-oneNom IUPAC
C19H24N2OFormule chimique
296.4 g/molMasse molaire
Palonosetron; 135729-61-2; (-)-Palonosetron; 2-Qhbiqo; Palonosetronum; Palonosetron, (3as, 3s)-; (3aS)-2-[(3S)-1-azabicyclo[2.2.2]octan-3-yl]-3a,4,5,6-tetrahydro-3H-benzo[de]isoquinolin-1-one; 5D06587D6R; NSC-743769; CHEBI:85161; 2-(1-Azabicyclo(2.2.2)oct-3-yl)-2,3,3a,4,5,6-hexahydro-1H-benz(de)isoquinolin-1-one; (3aS)-2-[(3S)-1-azabicyclo[2.2.2]octan-3-yl]-2,3,3a,4,5,6-hexahydro-1H-benzo[de]isoquinolin-1-one; 1H-Benz(de)isoquinolin-1-one, 2-(1-azabicyclo(2.2.2)oct-3-yl)-2,3,3a,4,5,6-hexahydro-, (S-(R*,R*))-; RS-25233-198; RS-25259-198; (3aS)-2-((3S)-1-azabicyclo(2.2.2)octan-3-yl)-2,3,3a,4,5,6-hexahydro-1H-benzo(de)isoquinolin-1-one; (3aS)-2-((3S)-1-azabicyclo(2.2.2)octan-3-yl)-3a,4,5,6-tetrahydro-3H-benzo(de)isoquinolin-1-one; RS-25259; RefChem:56726; DTXCID6028317; A04AA05; RS25259; RS25233197; RS25233198; RS25259197; RS25259198; RS 25233197; RS 25233198; RS 25259197; RS 25259198; RS 25233 197; RS 25233 198; RS 25259 197; RS 25259 198; (5S)-3-((3S)-1-azabicyclo(2.2.2)octan-3-yl)-3-azatricyclo(7.3.1.0?,13)trideca-1(12),9(13),10-trien-2-one; 1H-Benz(de)isoquinolin-1-one, 2-((3S)-1-azabicyclo(2.2.2)oct-3-yl)-2,3,3a,4,5,6-hexahydro-, (3aS)-; DTXSID5048342; Aloxi; Palonosetron [INN]; Aloxi (TN); MFCD07783848; Palonosetron (INN); (S)-2-((S)-quinuclidin-3-yl)-2,3,3a,4,5,6-hexahydro-1H-benzo[de]isoquinolin-1-one; (3~{a}~{S})-2-[(3~{S})-1-azabicyclo[2.2.2]octan-3-yl]-3~{a},4,5,6-tetrahydro-3~{H}-benzo[de]isoquinolin-1-one; UNII-5D06587D6R; Palonosetron; Aloxi; PALONOSETRON [MI]; SCHEMBL3746; PALONOSETRON [VANDF]; (S-(R*,R*))-2-(1-Azabicyclo(2.2.2)oct-3-yl)-2,3,3a,4,5,6-hexahydro-1H-benz(de)isoquinolin-1-one; PALONOSETRON [WHO-DD]; GTPL7486; orb1704804; CHEMBL1189679; SCHEMBL13391549; CPZBLNMUGSZIPR-NVXWUHKLSA-N; GLXC-05581; HMS3886A22; HY-A0018; BDBM50417287; EBC-07664; s5740; AKOS015967749; AKOS025311243; CS-0385; DB00377; NSC 743769; Ritanine (fosrolapitant + palonosetron); NCGC00271490-04; NCGC00271490-05; AS-35217; DA-66465; D07175; EN300-220764; T22393; AB00698542-05; AB00698542_07; BRD-K08924299-003-06-1; Z2185274784; (3aS)-2-[(3S)-quinuclidin-3-yl]-3a,4,5,6-tetrahydro-3H-benzo[de]isoquinolin-1-one; (5S)-3-[(3S)-1-azabicyclo[2.2.2]octan-3-yl]-3-azatricyclo[7.3.1.0,5,13]trideca-1(12),9(13),10-trien-2-one; 1021481-16-2; 1H-BENZ(DE)ISOQUINOLIN-1-ONE, 2-(3S)-1-AZABICYCLO(2.2.2)OCT-3-YL-2,3,3A,4,5,6-HEXAHYDRO-, (3AS)-; Palonosetron; 1H-Benz[de]isoquinolin-1-one, 2-(3S)-1-azabicyclo[2.2.2]oct-3-yl-2,3,3a,4,5,6-hexahydro-, (3aS)-; 1H-Benz[de]isoquinolin-1-one, 2-(1-azabicyclo[2.2.2]oct-3-yl)-2,3,3a,4,5,6-hexahydro-, [S-(R*,R*)]-; (-)-Palonosetron; (3aS)-2-(3S)-1-Azabicyclo[2.2.2]oct-3-Synonymes
Produits contenant Palonosetron
PalsetPalono-BFSAloxi solution for InjectionAloxiPalohaltAloxiSendatron 250 microgramZoralonPalonosetron Bidiphar 0,25mg/5mlPalnosPalnos 75Themiset
Page 1 sur 5
Entreprises vendant Palonosetron
AP
Aurobindo Pharma LimitedIndiaCT
Công ty TNHH Sản xuất Dược phẩm Medlac Pharma ItalyViet NamPage 1 sur 4